Sanofi-Aventis Signs Deal with ThalesNano

ThalesNano Inc. (Budapest), a developer of micro-scale flow instruments for chemistry, says it has signed an R&D agreement with Sanofi-Aventis (Paris) that will focus on continuous process chemistry technologies to reduce drug realization time. The collaboration will study the use and application of ThalesNano’s continuous process chemistry technologies within the Sanofi-Aventis drug R&D process, from discovery to active pharmaceutical ingredients (API) production. “The ThalesNano continuous process technology is already well-established in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers